Rotundic Acid Induces DNA Damage and Cell Death in Hepatocellular Carcinoma Through AKT/mTOR and MAPK Pathways

Overview

Journal Front Oncol

Specialty Oncology

Date 2019 Jul 12

PMID 31293977

Citations 12

Authors

Gaurab Roy

Su Guan

Hexiang Liu

Lei Zhang

Affiliations

Soon will be listed here.

Abstract

Hepatocellular carcinoma (HCC) is the fourth largest cause of cancer-related deaths worldwide with limited therapeutic interventions. Renewed interest in natural products as drug leads has resulted in a paradigm shift toward the rapid screening of medicinal plants for the discovery of new chemical entities. Rotundic acid (RA), a plant-derived triterpenoid, has been anecdotally reported to possess anti-inflammatory and cardio-protective abilities. The present study highlights the anti-cancer efficacy of RA on HCC and . The inhibitory effects of RA on HCC cell viability was determined by MTT. Soft agar colony formation and clonogenic assays also showed that RA inhibited HCC cell proliferation. Flow cytometry, confocal, and western blot results further indicated that RA induced cell cycle arrest, DNA damage, and apoptosis by modulating the AKT/mTOR and MAPK pathways. Besides the suppression of migration and invasion, tube formation and VEGF-ELISA revealed the anti-angiogenic abilities of RA on HCC. Moreover, RA also inhibited tumor growth in a HepG2 xenograft mouse model. To our best knowledge, this is the first extensive study of the anticancer activity of RA on HCC. The results demonstrate that RA could be a potential drug candidate for HCC treatment.

Citing Articles

Natural compounds as regulators of miRNAs: exploring a new avenue for treating colorectal cancer.

Doghish A, Mageed S, Mohammed O, Abdel-Reheim M, Zaki M, Mohamed A Funct Integr Genomics. 2025; 25(1):42.

PMID: 39982533 DOI: 10.1007/s10142-025-01547-8.

Targeting the mTOR Pathway in Hepatocellular Carcinoma: The Therapeutic Potential of Natural Products.

Chen G, Zhang Y, Zhou Y, Luo H, Guan H, An B J Inflamm Res. 2024; 17:10421-10440.

PMID: 39659752 PMC: 11630751. DOI: 10.2147/JIR.S501270.

A Gluconeogenesis-Related Genes Model for Predicting Prognosis, Tumor Microenvironment Infiltration, and Drug Sensitivity in Hepatocellular Carcinoma.

Tang X, Xue J, Zhang J, Zhou J J Hepatocell Carcinoma. 2024; 11:1907-1926.

PMID: 39386981 PMC: 11463187. DOI: 10.2147/JHC.S483664.

Rotundic acid improves nonalcoholic steatohepatitis in mice by regulating glycolysis and the TLR4/AP1 signaling pathway.

Shi X, Zheng X, Liu H, Han X, Zhang L, Hu B Lipids Health Dis. 2023; 22(1):214.

PMID: 38049817 PMC: 10694891. DOI: 10.1186/s12944-023-01976-z.

Modulation of hypoxia-inducible factor-1 signaling pathways in cancer angiogenesis, invasion, and metastasis by natural compounds: a comprehensive and critical review.

Fakhri S, Moradi S, Faraji F, Kooshki L, Webber K, Bishayee A Cancer Metastasis Rev. 2023; 43(1):501-574.

PMID: 37792223 DOI: 10.1007/s10555-023-10136-9.

References

Persons D, Yazlovitskaya E, Pelling J . Effect of extracellular signal-regulated kinase on p53 accumulation in response to cisplatin. J Biol Chem. 2000; 275(46):35778-85. DOI: 10.1074/jbc.M004267200. View

Mandlekar S, Kong A . Mechanisms of tamoxifen-induced apoptosis. Apoptosis. 2001; 6(6):469-77. DOI: 10.1023/a:1012437607881. View

Issbrucker K, Marti H, Hippenstiel S, Springmann G, Voswinckel R, Gaumann A . p38 MAP kinase--a molecular switch between VEGF-induced angiogenesis and vascular hyperpermeability. FASEB J. 2002; 17(2):262-4. DOI: 10.1096/fj.02-0329fje. View

Luciano F, Jacquel A, Colosetti P, Herrant M, Cagnol S, Pages G . Phosphorylation of Bim-EL by Erk1/2 on serine 69 promotes its degradation via the proteasome pathway and regulates its proapoptotic function. Oncogene. 2003; 22(43):6785-93. DOI: 10.1038/sj.onc.1206792. View

Olson J, Hallahan A . p38 MAP kinase: a convergence point in cancer therapy. Trends Mol Med. 2004; 10(3):125-9. DOI: 10.1016/j.molmed.2004.01.007. View

Zhang K, Chow P . The effect of megestrol acetate on growth of HepG2 cells in vitro and in vivo. Clin Cancer Res. 2004; 10(15):5226-32. DOI: 10.1158/1078-0432.CCR-04-0061. View

Nakanishi K, Sakamoto M, Yamasaki S, Todo S, Hirohashi S . Akt phosphorylation is a risk factor for early disease recurrence and poor prognosis in hepatocellular carcinoma. Cancer. 2004; 103(2):307-12. DOI: 10.1002/cncr.20774. View

Sahin F, Kannangai R, Adegbola O, Wang J, Su G, Torbenson M . mTOR and P70 S6 kinase expression in primary liver neoplasms. Clin Cancer Res. 2004; 10(24):8421-5. DOI: 10.1158/1078-0432.CCR-04-0941. View

Greten T, Papendorf F, Bleck J, Kirchhoff T, Wohlberedt T, Kubicka S . Survival rate in patients with hepatocellular carcinoma: a retrospective analysis of 389 patients. Br J Cancer. 2005; 92(10):1862-8. PMC: 2361778. DOI: 10.1038/sj.bjc.6602590. View

10.

Kim Y, Kim H, Hwa Kwon C, Kim J, Woo J, Jung J . Role of ERK activation in cisplatin-induced apoptosis in OK renal epithelial cells. J Appl Toxicol. 2005; 25(5):374-82. DOI: 10.1002/jat.1081. View

11.

Gao C, Xie Q, Su Y, Koeman J, Khoo S, Gustafson M . Proliferation and invasion: plasticity in tumor cells. Proc Natl Acad Sci U S A. 2005; 102(30):10528-33. PMC: 1180792. DOI: 10.1073/pnas.0504367102. View

12.

Balunas M, Kinghorn A . Drug discovery from medicinal plants. Life Sci. 2005; 78(5):431-41. DOI: 10.1016/j.lfs.2005.09.012. View

13.

Sieghart W, Fuereder T, Schmid K, Cejka D, Werzowa J, Wrba F . Mammalian target of rapamycin pathway activity in hepatocellular carcinomas of patients undergoing liver transplantation. Transplantation. 2007; 83(4):425-32. DOI: 10.1097/01.tp.0000252780.42104.95. View

14.

Ewings K, Hadfield-Moorhouse K, Wiggins C, Wickenden J, Balmanno K, Gilley R . ERK1/2-dependent phosphorylation of BimEL promotes its rapid dissociation from Mcl-1 and Bcl-xL. EMBO J. 2007; 26(12):2856-67. PMC: 1894764. DOI: 10.1038/sj.emboj.7601723. View

15.

McChesney J, Venkataraman S, Henri J . Plant natural products: back to the future or into extinction?. Phytochemistry. 2007; 68(14):2015-22. DOI: 10.1016/j.phytochem.2007.04.032. View

16.

El Mchichi B, Hadji A, Vazquez A, Leca G . p38 MAPK and MSK1 mediate caspase-8 activation in manganese-induced mitochondria-dependent cell death. Cell Death Differ. 2007; 14(10):1826-36. DOI: 10.1038/sj.cdd.4402187. View

17.

Butler M, Newman D . Mother Nature's gifts to diseases of man: the impact of natural products on anti-infective, anticholestemics and anticancer drug discovery. Prog Drug Res. 2007; 65:1, 3-44. DOI: 10.1007/978-3-7643-8117-2_1. View

18.

Chen Y, Paliwal S, Draheim K, Grossman S, Lewis B . p19Arf inhibits the invasion of hepatocellular carcinoma cells by binding to C-terminal binding protein. Cancer Res. 2008; 68(2):476-82. PMC: 2376045. DOI: 10.1158/0008-5472.CAN-07-1960. View

19.

Yi T, Cho S, Yi Z, Pang X, Rodriguez M, Wang Y . Thymoquinone inhibits tumor angiogenesis and tumor growth through suppressing AKT and extracellular signal-regulated kinase signaling pathways. Mol Cancer Ther. 2008; 7(7):1789-96. PMC: 2587125. DOI: 10.1158/1535-7163.MCT-08-0124. View

20.

Villanueva A, Chiang D, Newell P, Peix J, Thung S, Alsinet C . Pivotal role of mTOR signaling in hepatocellular carcinoma. Gastroenterology. 2008; 135(6):1972-83, 1983.e1-11. PMC: 2678688. DOI: 10.1053/j.gastro.2008.08.008. View